Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.45 |
| ▸ | AKT1 | P31749 | 1/20 | 0.45 |
| ▸ | AKT2 | P31751 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.44 |
| ▸ | DHODH | Q02127 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1303909 | 0.97 | KDM4E (0.53) | KDM4EL3MBTL1ATMLMNAMEN1 | |
| SCHEMBL4883632 | 0.95 | KDM4E (0.52) | KDM4EL3MBTL1ATMLMNAMEN1 | |
| SCHEMBL20886601 | 0.93 | L3MBTL1 (0.51) | KDM4EL3MBTL1ATMLMNAMEN1 | |
| SCHEMBL12690642 | 0.91 | L3MBTL1 (0.46) | KDM4EL3MBTL1ATMLMNAMEN1 | |
| SCHEMBL19655330 | 0.91 | L3MBTL1 (0.50) | KDM4EL3MBTL1ATMLMNAMEN1 | |
| SCHEMBL6725348 | 0.91 | L3MBTL1 (0.46) | KDM4EL3MBTL1ATMLMNAMEN1 | |
| SCHEMBL11987938 | 0.91 | L3MBTL1 (0.46) | KDM4EL3MBTL1ATMLMNAMEN1 | |
| SCHEMBL17759776 | 0.91 | L3MBTL1 (0.50) | KDM4EL3MBTL1ATMLMNAMEN1 | |
| SCHEMBL2853353 | 0.91 | L3MBTL1 (0.50) | KDM4EL3MBTL1ATMLMNAMEN1 | |
| SCHEMBL12690741 | 0.91 | L3MBTL1 (0.46) | KDM4EL3MBTL1ATMLMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210257559-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-08-19 | — | — | US | disclosed |
| US-10068533-B2 | Liquid crystal display device and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2018-09-04 | — | — | US | disclosed |
| US-20170186975-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-06-29 | — | — | US | disclosed |
| US-20170186975-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-06-29 | — | — | US | disclosed |
| US-20160225325-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LAB (JP) | 2016-08-04 | — | — | US | disclosed |
| US-9349325-B2 | Liquid crystal display device and electronic device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-05-24 | — | — | US | disclosed |
| US-9252380-B2 | Light-emitting device and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-02-02 | — | — | US | disclosed |
| EP-2366753-B1 | Light-Emitting Element and Lighting Device | SEMICONDUCTOR ENERGY LAB (JP) | 2015-06-17 | — | — | EP | disclosed |
| US-8564190-B2 | Light-emitting element and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-10-22 | — | — | US | disclosed |
| US-20120241794-A1 | Light-Emitting Device and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-09-27 | — | — | US | disclosed |
| WO-2012128188-A1 | LIGHT-EMITTING DEVICE AND LIGHTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-09-27 | — | — | WO | disclosed |
| US-8178216-B2 | Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-05-15 | — | — | US | disclosed |
| US-8178216-B2 | Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-05-15 | — | — | US | disclosed |
| US-20110267330-A1 | LIQUID CRYSTAL DISPLAY DEVICE AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-11-03 | — | — | US | disclosed |
| EP-2366753-A1 | Light-Emitting Element and Lighting Device | Semiconductor Energy Laboratory Co, Ltd. (JP) | 2011-09-21 | — | — | EP | disclosed |
| US-20110215714-A1 | Light-Emitting Element and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2011-09-08 | — | — | US | disclosed |
| US-20090072718-A1 | Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-03-19 | — | — | US | disclosed |
| US-20090072718-A1 | Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090072718-A1 | Quinoxaline derivative, and light-emitting element, light-emitting device, and electronic device including quinoxaline derivative | CRY1, GRK1, CRY2 | KDM4E 2006/4885L3MBTL1 826/4885ATM 2120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.